Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/16/2009 | WO2009088998A2 Glycosylation in avians |
07/16/2009 | WO2009088933A1 Methods and materials for targeted mutagenesis |
07/16/2009 | WO2009088928A2 Libraries, arrays and their uses for targeted affinity enhancement |
07/16/2009 | WO2009088876A2 Transgenic non-human animals expressing human blood clotting factors |
07/16/2009 | WO2009088837A2 Methods and products to target, capture and characterize stem cells |
07/16/2009 | WO2009088786A1 Rna interference for the treatment of heart failure |
07/16/2009 | WO2009088756A1 Gray leaf spot tolerant maize and methods of production |
07/16/2009 | WO2009088753A1 Isomerases, nucleic acids encoding them and methods for making and using them |
07/16/2009 | WO2009088737A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | WO2009088735A2 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | WO2009088732A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | WO2009088731A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | WO2009088730A1 Novel bacillus thuringiensis gene with coleopteran activity |
07/16/2009 | WO2009088405A2 System and method utilizing the expression of tlk1b protein in normal human cells to protect against dna damage |
07/16/2009 | WO2009088256A2 Baculovirus-based vaccines |
07/16/2009 | WO2009088216A1 L-threonine producing escherichia coli and process for producing l-threonine using same |
07/16/2009 | WO2009088183A1 Escherichia coli having an improved ability to produce l-threonine, and a method for producing l-threonine in which the said escherichia coli is employed |
07/16/2009 | WO2009088105A1 HUMANIZED ANTI-α9 INTEGRIN ANTIBODIES AND THE USES THEREOF |
07/16/2009 | WO2009088082A1 Method for specifically detecting test substance using photocurrent, sensor unit used therefor, and measuring device |
07/16/2009 | WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
07/16/2009 | WO2009088049A1 Method for production of desired substance by fermentation process |
07/16/2009 | WO2009088032A1 Antibody directed against pcrv |
07/16/2009 | WO2009087978A1 Anti-cldn6 antibody |
07/16/2009 | WO2009087967A1 Method for detecting a protein-protein interaction |
07/16/2009 | WO2009087949A1 Compound having heterocyclic ring, and use thereof |
07/16/2009 | WO2009087929A1 Novel glucose dehydrogenase |
07/16/2009 | WO2009087826A1 Recombinant expression plasmid vector and recombinant strain to be used in producing oxalate decarboxylase, and method of producing recombinant oxalate decarboxylase |
07/16/2009 | WO2009087580A2 Method and constructs for increasing recombinant protein production in plants dehydration stress |
07/16/2009 | WO2009087394A1 Cren7 chimeric protein |
07/16/2009 | WO2009087391A1 Protein expression systems |
07/16/2009 | WO2009087230A1 Display vectors and methods and uses thereof |
07/16/2009 | WO2009087223A1 Novel gene sms 44 |
07/16/2009 | WO2009087173A2 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
07/16/2009 | WO2009087110A1 Secretable hiv entry inhibitory peptides for therapy of hiv infection |
07/16/2009 | WO2009087097A1 A fluorescent teo-hybrid (f2h) assay for direct visualization of protein interactions in living |
07/16/2009 | WO2009086920A1 Anti mif antibodies |
07/16/2009 | WO2009086591A1 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
07/16/2009 | WO2009070636A3 Engineered cells, imaging reporter gene/probe systems, and methods of imaging |
07/16/2009 | WO2009069986A3 Genetically-modified cell line for producing cloned miniature pigs for xenotransplantation and method for preparing the same. |
07/16/2009 | WO2009068308A3 New malonate decarboxylases for industrial applications |
07/16/2009 | WO2009066071A3 Antisense oligonucleotides for the modulation of gene expression and methods relating to the use thereof |
07/16/2009 | WO2009061851A3 Modulation of factor 7 expression |
07/16/2009 | WO2009051439A3 Method of identifying agents which modulate the activity of calcium-activated chloride channel |
07/16/2009 | WO2009048932A3 Methods to regulate mirna processing by targeting lin-28 |
07/16/2009 | WO2009046397A3 Modulating gene expression with agrna and gapmers targeting antisense transcripts |
07/16/2009 | WO2009042971A8 Synthetic 5'utrs, expression vectors, and methods for increasing transgene expression |
07/16/2009 | WO2009038707A3 Cancer-testis gene silencing agents and uses thereof |
07/16/2009 | WO2009026653A8 Neuroplasticity assay |
07/16/2009 | WO2009026317A3 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
07/16/2009 | WO2009020609A3 Isolation of nucleic acids molecules using modified solid supports |
07/16/2009 | WO2008153745A3 Compositions and methods for producing bioactive fusion proteins |
07/16/2009 | WO2008146019A8 Method for baculovirus generation from insect cells in high-troughput plates |
07/16/2009 | WO2008131431A8 Modulation of blood brain barrier protein expression |
07/16/2009 | WO2008131426A8 RIBOSOMAL PROTEIN S3: A FUNCTIONAL COMPONENT OF NF-KAPPA B p65 BINDING COMPLEXES |
07/16/2009 | WO2008127450A8 Linear expression cassette vaccines |
07/16/2009 | WO2008119134A8 Methods for producing secondary metabolites |
07/16/2009 | WO2008112645A8 Methods for plant transformation using spectinomycin selection |
07/16/2009 | WO2008109506A8 Nucleic acid compounds for inhibiting jun gene expression and uses thereof |
07/16/2009 | WO2008109500A8 Nucleic acid compounds for inhibiting prkca gene expression and uses thereof |
07/16/2009 | WO2008109454A8 Nucleic acid compounds for inhibiting fos gene expression and uses thereof |
07/16/2009 | WO2008100545A8 Production of arachidonic acid in oilseed plants |
07/16/2009 | WO2008099185A8 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
07/16/2009 | WO2008096070A8 Cell line having a high transcription activity for the production of proteins, in particular therapeutic proteins |
07/16/2009 | WO2008093521A8 Method of assessing gene examination data, program therefor and apparatus of the same |
07/16/2009 | WO2008093010A8 Method for the random diversification of a genetic sequence while preserving the identity of some inner segments of said genetic sequence |
07/16/2009 | WO2008093009A8 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
07/16/2009 | WO2008092081A8 Targeted delivery of sirna |
07/16/2009 | WO2008088236A8 Method for genetically identifying a person according to the analysis of the single nucleotide polymorphism of a human genom by means of a oligonucleotide biological microchip (biochip) |
07/16/2009 | WO2008085797A8 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
07/16/2009 | WO2008066931A8 Bacillus licheniformis chromosome |
07/16/2009 | WO2008061240A8 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics in response to cold |
07/16/2009 | WO2008044068A8 Combination therapy |
07/16/2009 | WO2008043145A8 Hybridomas producing antibodies against non functional p2x7 receptor |
07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
07/16/2009 | WO2008015383A8 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
07/16/2009 | WO2008001045A8 Members of the glycoside hydrolase family 31 family of proteins |
07/16/2009 | WO2008000028A8 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
07/16/2009 | WO2007140339A8 Production of isoprenoids |
07/16/2009 | WO2007138253A8 Screening method |
07/16/2009 | WO2007138193A8 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
07/16/2009 | WO2007136303A8 Method for detecting uro-genital infection, oligonucleotide, oligonucleotide combination, biochip and a set based thereon |
07/16/2009 | WO2007122405A8 Polyhedral nanostructures formed from nucleic acids |
07/16/2009 | WO2007110619A8 Beta-galactosidase with transgalactosylating activity |
07/16/2009 | WO2007107775A8 Preparation of oligonucleotides with photoswitchable properties |
07/16/2009 | WO2007103383A8 Plant-specific genetic elements and transfer cassettes for plant transformation |
07/16/2009 | WO2007099231A8 System for the expression of a gene of interest in yeast |
07/16/2009 | WO2004022771A3 Short interfering nucleic acid hybrids and methods thereof |
07/16/2009 | WO2004015068A9 Identification of seeds or plants using phenotypic markers |
07/16/2009 | WO2003051720A3 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
07/16/2009 | WO2003002723A3 Mating-based method for detecting protein-protein interaction |
07/16/2009 | WO2002086063A3 Xenobiotic compound modulated expression systems and uses therefor |
07/16/2009 | WO2002083925A3 Papaya ringspot virus genes |
07/16/2009 | US20090183286 Promoter molecules for use in plants |
07/16/2009 | US20090183285 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
07/16/2009 | US20090183284 Nucleotide seqeunces mediating male fertility and method of using same |
07/16/2009 | US20090183283 Rice promoters for regulation of plant expression |
07/16/2009 | US20090183282 Insecticidal compounds and methods for selection thereof |
07/16/2009 | US20090183281 Use of histone chaperone activity of agrobacterium 6b protein |
07/16/2009 | US20090183280 Transgenic Plants Modified for Reduced Cadmium Transport, Derivative Products, and Related Methods |